Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
go back to main search page
Accession:CHEBI:114242 term browser browse the term
Definition:An oxadiazole that has formula C23H26N4O2.
Synonyms:related_synonym: Formula=C23H26N4O2;   InChI=1S/C23H26N4O2/c1-17-6-8-19(9-7-17)23-25-22(29-26-23)11-10-21(28)24-13-15-27-14-12-18-4-2-3-5-20(18)16-27/h2-9H,10-16H2,1H3,(H,24,28);   InChIKey=ZWRRCMRKCLGPSK-UHFFFAOYSA-N;   SMILES=CC1=CC=C(C=C1)C2=NOC(=N2)CCC(=O)NCCN3CCC4=CC=CC=C4C3
 xref: LINCS:LSM-25703


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 0
    chemical entity 0
      molecular entity 0
        polyatomic entity 0
          molecule 0
            cyclic compound 0
              ring assembly 0
                N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 0
    subatomic particle 0
      composite particle 0
        hadron 0
          baryon 0
            nucleon 0
              atomic nucleus 0
                atom 0
                  main group element atom 0
                    p-block element atom 0
                      carbon group element atom 0
                        carbon atom 0
                          organic molecular entity 0
                            organic molecule 0
                              organic cyclic compound 0
                                organic heterocyclic compound 0
                                  organic heteromonocyclic compound 0
                                    oxadiazole 0
                                      N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.